Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CARVEDILOL | 12.5MG | TABLET | Resolved | 2017-11-28 | 2018-05-27 | 30992 |
| APO-CARVEDILOL | 12.5MG | TABLET | Resolved | 2023-09-01 | 2023-11-17 | 203554 |
| APO-CEFACLOR | 250MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 19036 |
| APO-CEFACLOR | 500MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 19039 |
| APO-CEFACLOR | 125MG | POWDER | Actual shortage | 2017-08-13 | 2017-10-05 | 19066 |
| APO-CEFACLOR | 250MG | POWDER | Actual shortage | 2017-08-13 | 2017-10-05 | 19069 |
| APO-CEFACLOR | 375MG | POWDER | Actual shortage | 2017-08-13 | 2017-10-05 | 19072 |
| APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2024-07-25 | 2024-08-09 | 233706 |
| APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2024-09-12 | 2024-10-11 | 237372 |
| APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2024-11-14 | 2024-12-13 | 243086 |
| APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2019-07-12 | 2019-11-25 | 89155 |
| APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2023-04-21 | 2024-03-08 | 190008 |
| APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2025-01-16 | 2025-02-28 | 247862 |
| APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2021-07-23 | 2021-10-12 | 142973 |
| APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2017-04-17 | 2017-04-25 | 7102 |
| APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2022-11-20 | 2022-12-23 | 175327 |
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2022-04-08 | 2022-08-24 | 158348 |
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2019-03-27 | 2019-03-29 | 79574 |
| APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Resolved | 2019-07-31 | 2019-08-02 | 90341 |
| APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Resolved | 2019-12-05 | 2020-02-18 | 100265 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DILTIAZ TZ | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1078 |
| APO-DIPYRIDAMOLE | 25MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101888 |
| APO-DIPYRIDAMOLE | 50MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101891 |
| APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
| APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2018-09-15 | 60438 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60443 |
| APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60447 |
| APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-10-12 | 60450 |
| APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60453 |
| APO-DOXY CAP 100MG | 100MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-29 | 60459 |
| APO-DOXY TABS 100MG | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4707 |
| APO-ENALAPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-12-05 | 60462 |
| APO-ENALAPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-19 | 60465 |
| APO-ENALAPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60468 |
| APO-ESCITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60471 |
| APO-ESCITALOPRAM | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-11-16 | 60474 |
| APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 |